Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19

Tetiana Yatsenko; Ricardo Rios; Tatiane Nogueira; Yousef Salama; Satoshi Takahashi; Yoko Tabe; Toshio Naito; Kazuhisa Takahashi; Koichi Hattori; Beate Heissig

doi:10.3389/fimmu.2024.1390698

Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19

Front Immunol. 2024 Mar 13:15:1390698. doi: 10.3389/fimmu.2024.1390698. eCollection 2024.

Authors

Tetiana Yatsenko^{1

2}, Ricardo Rios³, Tatiane Nogueira³, Yousef Salama⁴, Satoshi Takahashi⁵, Yoko Tabe¹, Toshio Naito¹, Kazuhisa Takahashi^{1

6}, Koichi Hattori^{7

8}, Beate Heissig¹

Affiliations

¹ Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
² Department of Enzymes Chemistry and Biochemistry, Palladin Institute of Biochemistry of the National Academy of Science of Ukraine, Kyiv, Ukraine.
³ Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil.
⁴ An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
⁵ Division of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
⁶ Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.
⁷ Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan.
⁸ Department of Hematology/Oncology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1299792.].

Keywords: C-reactive protein; COVID-19; fibrinolysis; interleukin-6; plasminogen activator inhibitor-1; respiratory distress syndrome; thrombosis; urokinase-type plasminogen activator.

Publication types

Published Erratum